DOI:
10.1055/s-00025479
Experimental and Clinical Endocrinology & Diabetes Reports
LinksClose Window
References
van der Lely AJ, Muller A, Janssen JA. et al.
Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patient.
J Clin Endocrinol Metab 2001;
86: 478-481
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.